NCT03151148: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03151148 |
|---|---|
| Title | A First in Man Evaluation of the Safety and Efficacy of an Allogeneic Targeted Microbiome Transplant in Adults With Moderate-to-Severe Atopic Dermatitis (ADRN-08) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 28, 2017 |
| Completion date | May 14, 2019 |
| Required reporting date | May 13, 2020, midnight |
| Actual reporting date | May 6, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |